USE OF PYRIDYLBIPHOSPHONATES AS THERAPEUTIC AGENT

organic chemistry, medicine. SUBSTANCE: invention relates to use of pyridinylaminomethylidenebiphosphonic acid tetraalkyl esters for treatment of bone sicknesses, for example, bone osteolytic disease associated with malignant neoplasm, Paget's disease, primary and secondary osteoporosis and als...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RAJJA SELLMAN, KALERVO VJAJANJANEN, RITVA KHANNUNIEMI, SIRPA LIUKKO-SIPI, MAR'JANA KHEJKKILJA-KHOJKKA, KHANNU NIKANDER, TERTTU KLEJMOLA, LENA LAUREN
Format:	Patent
Sprache:	eng
Schlagworte:	ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	organic chemistry, medicine. SUBSTANCE: invention relates to use of pyridinylaminomethylidenebiphosphonic acid tetraalkyl esters for treatment of bone sicknesses, for example, bone osteolytic disease associated with malignant neoplasm, Paget's disease, primary and secondary osteoporosis and also to pharmaceutical composition and method of treatment of bone sicknesses. EFFECT: enhanced effectiveness of treatment. 7 cl, 1 dwg, 4 tbl, 4 ex